Back

Novartis investor urges board shake-up after trial failures, cites $12 billion deal

Verifying
  • David Samra urged Giovanni Caforio to improve Novartis' board oversight of acquisitions.
  • Novartis shares rose 1.30% to $139.27 in Friday premarket trading.
  • Artisan Partners became the first shareholder to publicly demand Novartis board reforms.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.